Elacestrant, a selective estrogen receptor degrader, demonstrated significant improvements in progression-free survival (PFS) ...

While the Medicare Competitive Bidding Program reduced spending, it did not significantly impact supplemental oxygen use or ...

Matias Sanchez, MD, assistant professor in the Department of Medicine, Division of Hematology and Oncology, University of Illinois Chicago, emphasizes the importance of patient education and caregiver ...

Palliative care is quality care, and providers and health systems need to do a better job at ensuring there is equity in ...

Food insecurity is a significant public health concern that disproportionately affects marginalized communities, contributing ...

The European Commission has approved mirvetuximab soravtansine for select patients with pretreated folate receptor–alpha (FRα)-positive, platinum-resistant ovarian cancer.

Investigators said patients experienced adverse effects in line with those expected for myeloablative conditioning with ...

The single-center report showed the therapy had a favorable safety profile and manageable side effects in children with ...

Bhattacharya's nomination, alongside Robert F. Kennedy Jr. and Mehmet Oz, indicates potential shifts in vaccine policy under ...

Divya Gupta, MD, assistant professor at Feinberg School of Medicine at Northwestern University, discussed the potential of using circulating tumor DNA and minimal residual disease (MRD) assays for ...

While name brands like Adderall and Vyvanse may have been recently removed from the FDA Drug Shortage Database, it's unclear ...

Accompanying these findings is a call for refined treatment strategies that have potential to better outcomes among patients ...